• Prevalence of Human Papillomavirus Infection Differs for Men and Women
    ALEXANDRIA, Va. -- The age-specific prevalence of sexually transmitted human papillomavirus infection in women differs substantially from that in men who have sex with men, according to a new study published in the Dec. 15, 2004 issue of The Journal of Infectious Diseases, ...More
    November 16, 2004 Posted in News
  • Brain’s Immune System Triggered in Autism
    A Johns Hopkins study has found new evidence that the brains of some people with autism show clear signs of inflammation, suggesting that the disease may be associated with activation of the brain’s immune system. “These findings reinforce the theory that immune response in ...More
    November 16, 2004 Posted in News
  • Community Living Causes Bacteria to Diversify
    Diversification is a strategy that strengthens groups of all kinds -- from forests challenged with environmental stress to stock market portfolios in uncertain times. Findings from University of Iowa researchers show that even bacteria have learned this important lesson. ...More
    November 16, 2004 Posted in News, Disinfection & Sterilization
  • Lyme Disease Receptor Identified in Tick Guts
    Researchers at Yale School of Medicine have identified a Lyme disease receptor called TROSPA that is used by disease agents to invade ticks. Lyme disease, the most common tick-borne disease in the United States, is caused by spirochete bacteria Borrelia burgdorferi, which ...More
    November 16, 2004 Posted in News
  • Avian Cholera Could Spread From Great Salt Lake
    Scientists at the U.S. Geological Survey’s (USGS) National Wildlife Health Center are concerned that avian cholera, which recently killed about 30,000 eared grebes -- small, diving water birds --at Great Salt Lake, Utah, could spread as birds migrate south for the winter, ...More
    November 16, 2004 Posted in News
  • Chiron Concludes Phase III Program for Menjugate Meningococcal C Vaccine in United States
    EMERYVILLE, Calif. -- Chiron Corporation announced that it has successfully concluded its Phase III trial for Menjugate® meningococcal C vaccine in the United States and will not be filing a Biologics License Application (BLA) for the vaccine. The now-completed Phase III ...More
    November 16, 2004 Posted in News
  • B. Braun Medical Providing Safer DEHP-free Device Options for Preemies, Neonates and Other At-risk Populations
    BETHLEHEM, Pa. -- To help improve patient outcomes and enable healthcare providers to comply more rapidly with FDA recommendations concerning limiting exposure to DEHP, a plasticizer in some PVC-based devices, B. Braun Medical Inc. announced that more ...More
    November 16, 2004 Posted in News
  • Living in Biofilms Causes Bacteria to Diversify
    Findings from University of Iowa researchers show that bacteria have learned that there is strength in diversification. When disease-causing bacteria assemble into communities known as biofilms, the individual bacteria rapidly diversify. This diversity increases the ...More
    November 16, 2004 Posted in News, Disinfection & Sterilization
  • University to Study Genetics’ Role in Vaccine Response
    The University of Alabama at Birmingham (UAB) has received a five-year, $12 million contract from the National Institute of Allergy and Infectious Diseases to study genetic factors that influence how well individuals respond to the anthrax vaccine. “This research will ...More
    November 15, 2004 Posted in News
  • Effective Treatment for Fever Syndrome Caused by Cold Exposure
    Remember when Grandma used to say ‘don’t go out in the cold; you’ll get sick”? It turns out that she was right for a small number of people who have a condition called familial cold autoinflammatory syndrome (FCAS), in which individuals are afflicted by rash, fever, joint ...More
    November 12, 2004 Posted in News